Fortis Healthcare Limited

NSE FORTIS.NS

Fortis Healthcare Limited Free Cash Flow for the year ending March 31, 2024: USD 18.90 M

Fortis Healthcare Limited Free Cash Flow is USD 18.90 M for the year ending March 31, 2024, a -58.58% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Fortis Healthcare Limited Free Cash Flow for the year ending March 31, 2023 was USD 45.63 M, a -46.69% change year over year.
  • Fortis Healthcare Limited Free Cash Flow for the year ending March 31, 2022 was USD 85.59 M, a 134.74% change year over year.
  • Fortis Healthcare Limited Free Cash Flow for the year ending March 31, 2021 was USD 36.46 M, a 1,654.83% change year over year.
  • Fortis Healthcare Limited Free Cash Flow for the year ending March 31, 2020 was USD 2.08 M, a 105.52% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
NSE: FORTIS.NS

Fortis Healthcare Limited

CEO Dr. Ashutosh Raghuvanshi
IPO Date May 9, 2007
Location India
Headquarters Tower A
Employees 12,088
Sector Health Care
Industries
Description

Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetes/endocrinology, emergency medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties. As of March 31, 2022, it operated a network of 26 hospitals with approximately 4,300 operational beds. The company also operates approximately 426 diagnostics centers and laboratories; and 2,550 collection centers. The company was incorporated in 1996 and is based in Gurugram, India.

Similar companies

APOLLOHOSP.NS

Apollo Hospitals Enterprise Limited

USD 77.49

-1.80%

IPCALAB.NS

Ipca Laboratories Limited

USD 18.35

0.69%

INDHOTEL.NS

The Indian Hotels Company Limited

USD 9.03

3.50%

GSPL.NS

Gujarat State Petronet Limited

USD 4.02

3.05%

GLENMARK.NS

Glenmark Pharmaceuticals Limited

USD 17.52

1.42%

StockViz Staff

January 15, 2025

Any question? Send us an email